Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 11/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 1/20 | 0.38 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13562218 | 0.96 | PTPN1 (0.49) | PTPN1CYP1A2CYP2D6CYP2C19NPC1 | |
| SCHEMBL13562219 | 0.92 | PTPN1 (0.46) | PTPN1CYP1A2CYP2D6CYP2C19NPC1 | |
| SCHEMBL15848809 | 0.91 | PTPN1 (0.45) | PTPN1CYP1A2CYP2D6CYP2C19MAPT | |
| SCHEMBL15848797 | 0.91 | PTPN1 (0.45) | PTPN1CYP1A2CYP2D6CYP2C19MAPT | |
| SCHEMBL15848807 | 0.91 | PTPN1 (0.45) | PTPN1CYP1A2CYP2D6CYP2C19MAPT | |
| SCHEMBL15848808 | 0.91 | PTPN1 (0.45) | PTPN1CYP1A2CYP2D6CYP2C19MAPT | |
| SCHEMBL15848796 | 0.91 | PTPN1 (0.45) | PTPN1CYP1A2CYP2D6CYP2C19MAPT | |
| SCHEMBL15848806 | 0.91 | PTPN1 (0.45) | PTPN1CYP1A2CYP2D6CYP2C19MAPT | |
| SCHEMBL15848795 | 0.91 | PTPN1 (0.45) | PTPN1CYP1A2CYP2D6CYP2C19MAPT | |
| SCHEMBL13562302 | 0.91 | PTPN1 (0.45) | PTPN1CYP1A2CYP2D6CYP2C19MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10777752-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10777752-B2 | Organic electroluminescence device and electronic apparatus provided with the same | RER1, RPS19, MRPS22 | PTPN1 4248/4885CYP1A2 1560/4885CYP2D6 2037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.